Internal Consistency Study of EORTC QLQ-C30 and QLQ-PR25 Questionnaires for Quality of Life Assessment among Prostate Cancer Patients in a University Hospital, Kuala Lumpur, Malaysia
- Author:
Norzaher Ismail
1
Author Information
1. Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Cheras, Malaysia
- Collective Name:Shamsul Azhar Shah; Syafiq Taib; Siti Nor Mat; Nazarudin Safianrtment of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Cheras, Malaysia
- Publication Type:Journal Article
- Keywords:
Quality of Life;
EORTC QLQ C30;
EORTC PR-25;
Prostate Cancer;
Malay Language.
- From:International Journal of Public Health Research
2020;10(1):1158-1165
- CountryMalaysia
- Language:English
-
Abstract:
Prostate cancer is forth most common diagnosed tumors in Malaysian male.
The use of a self-reported, quality of life assessment is important for clinical
practice, care taker and researcher to evaluate the level of quality of life. The
aim of this study was to measure the internal consistency of the translated
Malay Language EORTC QLQ-C30 and EORTC PR-25 questionnaires among
prostate cancer patient at National University of Malaysia hospital in Kuala
Lumpur, Malaysia.
Methods This was a cross sectional study conducted between July 2017 and Dec 2017.
The respondent comprised of 110 Malaysian prostate cancer patients who were
under follow up at Urology and Oncology Clinic. Sets of translated Malay
language EORTC QLQ C30 and EORTC PR-25 consisted of functional,
symptom and global health status domains were administered to assess their
quality of life.
Results The translated questionnaires were acceptable by 110 respondents. Cronbach`s
α coefficient result were 0.913 (EORTC QLQ-C30) and 0.829 (EORTC PR25) respectively suggested that this instrument had good internal consistency.
Conclusions Our study confirmed that translated Malay language EORTC QLQ-C30 and
QLQ-PR25 questionnaires are acceptable, reliable and valid instrument to be
used among Malaysian prostate cancer patients.
- Full text:21.2020my0233.pdf
